There are plenty of labels that could sum up the 2015 market and economy. It's been the year of the China slowdown scare, the oil bust, the rise of New Era growth stock dominance and the wait for the Fed to "lift off."
Yet, to an unappreciated degree, this was also the year that Main Street's fortunes began to improve more than Wall Street's.
Jim Cramer details what the rotation out of growth and into value means for the bull market.
Jim Cramer flies through his take on callers' favorite stocks, including a high-profile social media play.
Jim Cramer sits down with Yuval Cohen, the CEO of a company that is creating treatments derived from manmade cannabinoids for rare diseases like cystic fibrosis.
Jim Cramer doubles down on his warning about investing in marijuana stocks like Tilray, which has been trading wildly since CEO Brendan Kennedy's appearance on "Mad Money."
Get the best of CNBC in your inbox
Playing
Watch Next...
Data also provided by 
